Filiz Akyıldız Akçay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Filiz Akyıldız Akçay has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Selcen Yakar Tuluce
3 shared publications- Kamil Tuluce
Dept. of Cardiology, Karsiyaka State Hospital, Izmir, Turkey
2 shared publications - Sadık Volkan Emren
Department of Cardiology, Izmir Kâtip Çelebi University Faculty of Medicine, 35620 Izmir, Türkiye
2 shared publications - Tuncay Kiris
Department of Cardiology, Izmir Katip Çelebi University, Atatürk Training and Research Hospital, Izmir 35360, Turkey
2 shared publications - Abdullah Orhan Demirtas
Department of Cardiology, University of Health Sciences, Adana City Training and Research Hospital, 01230 Adana, Türkiye
1 shared publication - Alicia Arredondo Eve
Department of Food Science and Human Nutrition, University of Illinois Urbana-Champaign, Urbana, Illinois, United States of America
1 shared publication
Latest Publications
- 22 October 2025
- Published by Galenos Yayinevi in Cardiovascular Surgery and Interventions
- Vol. 12 (3) , 188-195
Age-related effect of trimetazidine in the prevention of contrast-induced nephropathy in patients with preserved renal function
Objectives: This study aims to investigate whether trimetazidine (TMZ) alone has a preventive effect on contrast-induced nephropathy (CIN) in patients with preserved kidney function who underwent angiographic procedures and the variables associated with CIN development. Patients and methods: Between June 2023 and September 2023, a total of 305 patients (199 males, 106 females; mean age: 60±10 years; range, 54 to 67 years) who underwent coronary angiographic procedures with diagnosed or suspected stable coronary artery disease and an estimated glomerular filtration rate (eGFR) of >60 mL/min/1.73 m2 were included. A total of 153 patients received TMZ (TMZ group), while 152 patients were naïve to TMZ (non-TMZ group). Results: Ten patients (6.5%) in the non-TMZ group and nine patients (5.8%) in the TMZ group developed CIN within 48 to 72 h (p=0.801) after the procedures. The mean serum creatinine level increased from 0.84±0.1 mg/dL to 0.89±0.2 mg/dL in the non-TMZ group (p<0.001) and from 0.84±0.1 mg/dL to 0.88±0.2 mg/dL in the TMZ group (p=0.008). Multivariate logistic regression analysis revealed that only age (odds ratio [OR]: 1.10, 95% CI: 1.03-1.18, p=0.003) was an independent predictor of CIN. A cut-off value of 60 years (area under the curve [AUC]=0.785; sensitivity, 100%; specificity, 52%) predicted CIN development in the non-TMZ group, whereas it was 72.5 years (AUC=0.711; sensitivity, 55%; specificity, 90%) for the TMZ group. Conclusion: Our study results suggest that the use of TMZ may be beneficial on CIN in elderly patients undergoing coronary angiographic procedures, even if the eGFR is ≥60 mL/min/1.73 m2.
- 22 October 2025
- Published by Galenos Yayinevi in Cardiovascular Surgery and Interventions
- Vol. 12 (3) , 188-195
Age-related effect of trimetazidine in the prevention of contrast-induced nephropathy in patients with preserved renal function
Objectives: This study aims to investigate whether trimetazidine (TMZ) alone has a preventive effect on contrast-induced nephropathy (CIN) in patients with preserved kidney function who underwent angiographic procedures and the variables associated with CIN development. Patients and methods: Between June 2023 and September 2023, a total of 305 patients (199 males, 106 females; mean age: 60±10 years; range, 54 to 67 years) who underwent coronary angiographic procedures with diagnosed or suspected stable coronary artery disease and an estimated glomerular filtration rate (eGFR) of >60 mL/min/1.73 m2 were included. A total of 153 patients received TMZ (TMZ group), while 152 patients were naïve to TMZ (non-TMZ group). Results: Ten patients (6.5%) in the non-TMZ group and nine patients (5.8%) in the TMZ group developed CIN within 48 to 72 h (p=0.801) after the procedures. The mean serum creatinine level increased from 0.84±0.1 mg/dL to 0.89±0.2 mg/dL in the non-TMZ group (p<0.001) and from 0.84±0.1 mg/dL to 0.88±0.2 mg/dL in the TMZ group (p=0.008). Multivariate logistic regression analysis revealed that only age (odds ratio [OR]: 1.10, 95% CI: 1.03-1.18, p=0.003) was an independent predictor of CIN. A cut-off value of 60 years (area under the curve [AUC]=0.785; sensitivity, 100%; specificity, 52%) predicted CIN development in the non-TMZ group, whereas it was 72.5 years (AUC=0.711; sensitivity, 55%; specificity, 90%) for the TMZ group. Conclusion: Our study results suggest that the use of TMZ may be beneficial on CIN in elderly patients undergoing coronary angiographic procedures, even if the eGFR is ≥60 mL/min/1.73 m2.
- Open Access
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (3) , 175
Reply to Letter to the Editor: “Sexual Dimorphism in the Heart Failure Population”
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (3) , 175
Open AccessReply to Letter to the Editor: “Sexual Dimorphism in the Heart Failure Population”
- Open Access
- 1 January 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (11) , 639-649
Gender-Related Differences in Patients with Acute Heart Failure: Observation from the Journey Heart Failure—Turkish Population Study
Gender-related clinical variations in patients with acute heart failure have been described in previous studies. However, there is still a lack of research on gender differences in patients hospitalized for acute heart failure in Türkiye. The aim of this study is to compare the clinical features, in-hospital approaches, and outcomes of male and female patients hospitalized for acute heart failure. Differences in clinical characteristics, medication prescription, hospital management, and outcomes between males and females with acute heart failure were investigated from the Journey Heart Failure—Turkish Population study. Nine hundred eighteen patients (57.2%) were men and 688 (42.8%) were women. Women were older than men (70.48 ± 13.20 years vs. 65.87 ± 12.82 years; P < .001). The frequency of comorbidities such as hypertension (72.7% vs. 62.4%, P <.001), diabetes (46.5% vs. 38.5%, P = .001), atrial fibrillation (46.5% vs. 33.4%, P < .001), New York Heart Association class III-IV symptoms (80.6% vs. 71.2%, P = .001), and dyspnea in the rest (73.8% vs. 68.3%, P = .044) were more common in women on admission. Male patients were more frequently hospitalized with reduced left ventricular ejection fraction (51.0% vs. 72.4%, P < .001). In-hospital mortality was higher among female patients (9.3% vs. 6.4%, P = .022). Higher New York Heart Association class, lower estimated glomerular filtration rate, higher N-terminal pro-B type natriuretic peptide on admission, and mechanical ventilation usage were the independent parameters of in-hospital mortality, whereas the female gender was not. Our study clearly demonstrated the diversity in presentation, management, and in-hospital outcomes of acute heart failure between male and female patients. Although left ventricular systolic functions were better in female patients, in-hospital mortality was higher. Recognizing these differences in the management of heart failure in different sexes will serve better results in clinical practice.
- 1 January 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (11) , 639-649
Open AccessGender-Related Differences in Patients with Acute Heart Failure: Observation from the Journey Heart Failure—Turkish Population Study
Gender-related clinical variations in patients with acute heart failure have been described in previous studies. However, there is still a lack of research on gender differences in patients hospitalized for acute heart failure in Türkiye. The aim of this study is to compare the clinical features, in-hospital approaches, and outcomes of male and female patients hospitalized for acute heart failure. Differences in clinical characteristics, medication prescription, hospital management, and outcomes between males and females with acute heart failure were investigated from the Journey Heart Failure—Turkish Population study. Nine hundred eighteen patients (57.2%) were men and 688 (42.8%) were women. Women were older than men (70.48 ± 13.20 years vs. 65.87 ± 12.82 years; P < .001). The frequency of comorbidities such as hypertension (72.7% vs. 62.4%, P <.001), diabetes (46.5% vs. 38.5%, P = .001), atrial fibrillation (46.5% vs. 33.4%, P < .001), New York Heart Association class III-IV symptoms (80.6% vs. 71.2%, P = .001), and dyspnea in the rest (73.8% vs. 68.3%, P = .044) were more common in women on admission. Male patients were more frequently hospitalized with reduced left ventricular ejection fraction (51.0% vs. 72.4%, P < .001). In-hospital mortality was higher among female patients (9.3% vs. 6.4%, P = .022). Higher New York Heart Association class, lower estimated glomerular filtration rate, higher N-terminal pro-B type natriuretic peptide on admission, and mechanical ventilation usage were the independent parameters of in-hospital mortality, whereas the female gender was not. Our study clearly demonstrated the diversity in presentation, management, and in-hospital outcomes of acute heart failure between male and female patients. Although left ventricular systolic functions were better in female patients, in-hospital mortality was higher. Recognizing these differences in the management of heart failure in different sexes will serve better results in clinical practice.
- Open Access
- 25 May 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 339
Identification of Circulating Diagnostic Biomarkers for Coronary Microvascular Disease in Postmenopausal Women Using Machine-Learning Techniques
Coronary microvascular disease (CMD) is a common form of heart disease in postmenopausal women. It is not due to plaque formation but dysfunction of microvessels that feed the heart muscle. The majority of the patients do not receive a proper diagnosis, are discharged prematurely and must go back to the hospital with persistent symptoms. Because of the lack of diagnostic biomarkers, in the current study, we focused on identifying novel circulating biomarkers of CMV that could potentially be used for developing a diagnostic test. We hypothesized that plasma metabolite composition is different for postmenopausal women with no heart disease, CAD, or CMD. A total of 70 postmenopausal women, 26 healthy individuals, 23 individuals with CMD and 21 individuals with CAD were recruited. Their full health screening and tests were completed. Basic cardiac examination, including detailed clinical history, additional disease and prescribed drugs, were noted. Electrocardiograph, transthoracic echocardiography and laboratory analysis were also obtained. Additionally, we performed full metabolite profiling of plasma samples from these individuals using gas chromatography-mass spectrometry (GC–MS) analysis, identified and classified circulating biomarkers using machine learning approaches. Stearic acid and ornithine levels were significantly higher in postmenopausal women with CMD. In contrast, valine levels were higher for women with CAD. Our research identified potential circulating plasma biomarkers of this debilitating heart disease in postmenopausal women, which will have a clinical impact on diagnostic test design in the future.
- 25 May 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 339
Open AccessIdentification of Circulating Diagnostic Biomarkers for Coronary Microvascular Disease in Postmenopausal Women Using Machine-Learning Techniques
Coronary microvascular disease (CMD) is a common form of heart disease in postmenopausal women. It is not due to plaque formation but dysfunction of microvessels that feed the heart muscle. The majority of the patients do not receive a proper diagnosis, are discharged prematurely and must go back to the hospital with persistent symptoms. Because of the lack of diagnostic biomarkers, in the current study, we focused on identifying novel circulating biomarkers of CMV that could potentially be used for developing a diagnostic test. We hypothesized that plasma metabolite composition is different for postmenopausal women with no heart disease, CAD, or CMD. A total of 70 postmenopausal women, 26 healthy individuals, 23 individuals with CMD and 21 individuals with CAD were recruited. Their full health screening and tests were completed. Basic cardiac examination, including detailed clinical history, additional disease and prescribed drugs, were noted. Electrocardiograph, transthoracic echocardiography and laboratory analysis were also obtained. Additionally, we performed full metabolite profiling of plasma samples from these individuals using gas chromatography-mass spectrometry (GC–MS) analysis, identified and classified circulating biomarkers using machine learning approaches. Stearic acid and ornithine levels were significantly higher in postmenopausal women with CMD. In contrast, valine levels were higher for women with CAD. Our research identified potential circulating plasma biomarkers of this debilitating heart disease in postmenopausal women, which will have a clinical impact on diagnostic test design in the future.
- 27 June 2020
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 50 (11) , e13271
Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study
Objective: Bleeding is one of the most important causes of mortality in patients with acute coronary syndrome (ACS). This study therefore aimed to investigate bleeding risk in patients with ACS who were scheduled to receive dual antiplatelet therapy (DAPT) in Turkey.Methods: This was a multicentre, observational, cross‐sectional cohort study. The study population included 963 patients with ACS from 12 centres in Turkey. We used the Predicting Bleeding Complication in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score to predict the bleeding risk for all the patients. The patients were divided into high (≥25) or low (˂25) bleeding risk groups based on their PRECISE‐DAPT scores.Results: The mean PRECISE‐DAPT score was 21.9. Overall, 32.2% of the patients had high PRECISE‐DAPT scores (≥25). Compared with the male patients, the female patients had higher PRECISE‐DAPT scores (28.2 ± 15.7 vs 18.4 ± 13.6, P ˂ .001). Among the females, the rate of patients with a PRECISE‐DAPT score ≥25 was 53%, while among the male patients, the score occurred at a rate of 22%. The female patients had lower haemoglobin (Hb) levels than the male patients (12.1 ± 1.7 vs 13.8 ± 1.9, P ˂ .001) and lower creatinine clearance (70.7 ± 27.5 vs 88.7 ± 26.3, P ˂ .001). The in‐hospital bleeding rates were higher among the patients with high PRECISE‐DAPT scores than among those who did not have high scores. Furthermore, the patients with high PRECISE‐DAPT scores had a higher in‐hospital mortality rate compared with those with low PRECISE‐DAPT scores (1% vs 0%, P = .11).Conclusions: The mean PRECISE‐DAPT score was high among the patients with ACS in this study, indicating that the bleeding tendency was high. This study showed that the PRECISE‐DAPT score may help physicians determine the type and duration of DAPT, especially in patients with ACS in Turkey.
- 27 June 2020
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 50 (11) , e13271
Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study
Objective: Bleeding is one of the most important causes of mortality in patients with acute coronary syndrome (ACS). This study therefore aimed to investigate bleeding risk in patients with ACS who were scheduled to receive dual antiplatelet therapy (DAPT) in Turkey.Methods: This was a multicentre, observational, cross‐sectional cohort study. The study population included 963 patients with ACS from 12 centres in Turkey. We used the Predicting Bleeding Complication in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score to predict the bleeding risk for all the patients. The patients were divided into high (≥25) or low (˂25) bleeding risk groups based on their PRECISE‐DAPT scores.Results: The mean PRECISE‐DAPT score was 21.9. Overall, 32.2% of the patients had high PRECISE‐DAPT scores (≥25). Compared with the male patients, the female patients had higher PRECISE‐DAPT scores (28.2 ± 15.7 vs 18.4 ± 13.6, P ˂ .001). Among the females, the rate of patients with a PRECISE‐DAPT score ≥25 was 53%, while among the male patients, the score occurred at a rate of 22%. The female patients had lower haemoglobin (Hb) levels than the male patients (12.1 ± 1.7 vs 13.8 ± 1.9, P ˂ .001) and lower creatinine clearance (70.7 ± 27.5 vs 88.7 ± 26.3, P ˂ .001). The in‐hospital bleeding rates were higher among the patients with high PRECISE‐DAPT scores than among those who did not have high scores. Furthermore, the patients with high PRECISE‐DAPT scores had a higher in‐hospital mortality rate compared with those with low PRECISE‐DAPT scores (1% vs 0%, P = .11).Conclusions: The mean PRECISE‐DAPT score was high among the patients with ACS in this study, indicating that the bleeding tendency was high. This study showed that the PRECISE‐DAPT score may help physicians determine the type and duration of DAPT, especially in patients with ACS in Turkey.
- 15 April 2020
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 23 (1) , 69-72
Percutaneous Retrieval of a Large Amplatzer Atrial Septal Occluder Device After Embolization to the Main Pulmonary Artery
- 15 April 2020
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 23 (1) , 69-72
Percutaneous Retrieval of a Large Amplatzer Atrial Septal Occluder Device After Embolization to the Main Pulmonary Artery
- Open Access
- 4 April 2014
- Published by AVES YAYINCILIK A.Ş. in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
- Vol. 14 (2) , 156-161
The effects of iodixanol and iopamidol on adhesion molecule serum levels in patients with angina pectoris undergoing coronary angiography: a randomized study
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology
- 4 April 2014
- Published by AVES YAYINCILIK A.Ş. in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
- Vol. 14 (2) , 156-161
Open AccessThe effects of iodixanol and iopamidol on adhesion molecule serum levels in patients with angina pectoris undergoing coronary angiography: a randomized study
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology